Sabina Wanjiru Chege

All parliamentary appearances

Entries 1381 to 1390 of 2784.

• 24 Oct 2018 in National Assembly: according to quality standards, and is designed to minimise risks involved in any pharmaceutical production that cannot be eliminated view
• 24 Oct 2018 in National Assembly: through testing the final product; view
• 24 Oct 2018 in National Assembly: “health facility” has the meaning assigned to it in the Health Act; view
• 24 Oct 2018 in National Assembly: “pharmaceutical device” includes human and veterinary medicines, medical products, medicinal substances, vaccines, diagnostics, blood view
• 24 Oct 2018 in National Assembly: products, therapeutic feeds, nutritional formulations, beauty products view
• 24 Oct 2018 in National Assembly: and related products; No. 21 of “pharmaceutical equipment” means equipment used in the 2017. manufacture and quality control of pharmaceutical products; view
• 24 Oct 2018 in National Assembly: “pharmaceutical practitioner” means a person lawfully carrying on the practice of pharmacy; “pharmaceutical product” means any material or product intended for human or veterinary use presented in its finished dosage or form, that is subject to control by or under this Act; “pharmaceutical technologist” means a holder of a diploma in pharmacy from a training institution recognised by the Board; “pharmacist” means a holder of a degree in pharmacy from a training institution recognised by the Board; “pharmacovigilance” means the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify ... view
• 24 Oct 2018 in National Assembly: pharmacovigilance; “practicing license” means a license issued under section 9A. view
• 24 Oct 2018 in National Assembly: The Committee has proposed to provide additional terms that are used in the Act but have previously not been included in the interpretation section such as “good manufacturing practice”, “pharmaceutical device” and “pharmaceutical technologist”. The proposed amendment further seeks to introduce interpretation of various technical terms, as used in the Act such as “clinical trials”, “health products”, “health technology”, “medicinal substances” and “medical device”. The Committee looked at the terms as per the World Health Organisation’s definitions. I therefore move the amendment. view
• 24 Oct 2018 in National Assembly: Hon. Temporary Deputy Chairlady, I beg to move: THAT, the Schedule to the Bill be amended - (b) by deleting the proposed amendments to section 3 and substituting therefor the following new amendments− s. 3 Delete and substitute therefor the following new section− Establishment 3.(1) There is established a Board which shall consist of− of the Pharmacy and Poisons (a) a Chairperson who shall be appointed by the President Board. and who shall− (i) be a pharmacist of good standing with a degree in pharmacy; and (ii) have at least fifteen years’ experience in the pharmaceutical sector; (b) the Director ... view